Kissing, Germany

Martin Ebner

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Martin Ebner

Introduction: Martin Ebner, an accomplished inventor located in Kissing, Germany, has made significant contributions to the field of epoxy resins through his innovative patents. With a total of eight patents to his name, Ebner has demonstrated a strong commitment to advancing material science and engineering.

Latest Patents: Among his latest innovations are two notable patents. The first patent focuses on a hardener and cure accelerant with a flame retardancy effect for curing epoxy resins. This invention explores novel hardeners designed to enhance the curing process while incorporating compounds from the group of esters of phosphorus-containing acids. The second patent relates to the use of N,N'-(dimethyl) urones as curing agents, offering a controlled method for curing epoxy resin compositions using bis- or multifunctional N,N'-(dimethyl) urons.

Career Highlights: Martin Ebner is currently employed at Alzchem AG, a company known for its focus on chemical production and innovation. Throughout his career, he has developed cutting-edge solutions to improve epoxy resin applications, emphasizing safety and efficiency in materials engineering.

Collaborations: Ebner has collaborated with esteemed colleagues Hans-Peter Krimmer and Sylvia Strobel. Their teamwork reflects a commitment to advancing research and development within their field, combining their expertise to drive impactful innovations.

Conclusion: Martin Ebner stands out as a significant figure in the realm of material science, particularly in the development of epoxy resins. His contributions through patents not only enhance the usability and safety of these materials but also reflect the ongoing evolution in the field. As he continues to work with Alzchem AG and collaborate with other experts, his further innovations are eagerly anticipated by the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…